These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5032508)

  • 1. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secretion of growth hormone and insulin in patients with acromegaly].
    Ulrich E; Seige K; Schneyer U; Wilhelmsen E; Hädecke J
    Z Gesamte Inn Med; 1973 Mar; 28(5):141-2 passim. PubMed ID: 4350299
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum-insulin in acromegaly.
    Elkeles RS; Wright AD; Lowy C; Fraser TR
    Lancet; 1969 Sep; 2(7621):615-8. PubMed ID: 4185594
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of estrogen therapy on carbohydrate metabolism in acromegaly.
    Mintz DH; Finster JL; Josimovich JB
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1321-7. PubMed ID: 4292250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Somatotropic function of the hypophysis. Tolerance tests as a method of evaluation of the somatotropic function of the hypophysis].
    Sokolov IaA; Vasilenko VV; Fedotov VP
    Probl Endokrinol (Mosk); 1974; 20(5):16-22. PubMed ID: 4445109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Somatotrophic response to hypoglycemic stimulus in patients with acromegaly. Effect of bromocriptine].
    Fiszlejder L; Bokser L; Puyo AM; Chervin AB; Guitelman A
    Medicina (B Aires); 1986; 46(1):16-24. PubMed ID: 3543606
    [No Abstract]   [Full Text] [Related]  

  • 10. Nocturnal monitoring of growth hormone, insulin, C-peptide, and glucose in patients with acromegaly.
    Tsai JS; Zorrilla LL; Jacob KK; Rosenberg S; Marcus DL
    Am J Med Sci; 1996 Jun; 311(6):281-5. PubMed ID: 8659555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of medroxyprogesterone acetate therapy on carbohydrate metabolism in acromegaly.
    Blum I; Karp M; Laron Z
    Isr J Med Sci; 1972 Jun; 8(6):881-2. PubMed ID: 5051830
    [No Abstract]   [Full Text] [Related]  

  • 12. [STH blood level after metopirone in 12 patients with acromegaly].
    Chiodini PG; Liuzzi A; Spinelli F; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):431-5. PubMed ID: 4664004
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum leptin levels in acromegaly--a significant role for adipose tissue and fasting insulin/glucose ratio.
    Bolanowski M; Milewicz A; Bidzińska B; Jedrzejuk D; Daroszewski J; Mikulski E
    Med Sci Monit; 2002 Oct; 8(10):CR685-9. PubMed ID: 12388920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 15. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
    Malarkey WB; Daughaday WH
    J Clin Endocrinol Metab; 1971 Sep; 33(3):424-31. PubMed ID: 4936883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin, glucagon and C-peptide content in the blood of acromegaly patients].
    Molitvoslovova NN
    Probl Endokrinol (Mosk); 1983; 29(3):21-4. PubMed ID: 6346317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acromegaly].
    Lindholm J; Korsgaard O; Rasmussen P; Kappelgaard AM
    Ugeskr Laeger; 1973 Jan; 135(4):183-7. PubMed ID: 4346376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of oral glucose tolerance in the diagnosis of acromegaly].
    von Werder K; Bottermann P; Hartmann P; Schwarz K
    Med Klin; 1972 Oct; 67(43):1398-401. PubMed ID: 4641922
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of somatotropic function of hypophysis in patients with acromegaly with the aid of the insulin tolerance tests].
    Sokolov IaA; Zarubina NA; Vasilenko VV; Balakhovskaia MI; Arapova SD
    Probl Endokrinol (Mosk); 1974; 20(6):42-6. PubMed ID: 4449815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.